These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

512 related articles for article (PubMed ID: 15728254)

  • 1. PITX2, beta-catenin and LEF-1 interact to synergistically regulate the LEF-1 promoter.
    Vadlamudi U; Espinoza HM; Ganga M; Martin DM; Liu X; Engelhardt JF; Amendt BA
    J Cell Sci; 2005 Mar; 118(Pt 6):1129-37. PubMed ID: 15728254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PITX2 and beta-catenin interactions regulate Lef-1 isoform expression.
    Amen M; Liu X; Vadlamudi U; Elizondo G; Diamond E; Engelhardt JF; Amendt BA
    Mol Cell Biol; 2007 Nov; 27(21):7560-73. PubMed ID: 17785445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Wnt-3A/beta-catenin signaling induces transcription from the LEF-1 promoter.
    Filali M; Cheng N; Abbott D; Leontiev V; Engelhardt JF
    J Biol Chem; 2002 Sep; 277(36):33398-410. PubMed ID: 12052822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tcf binding sequence and position determines beta-catenin and Lef-1 responsiveness of MMP-7 promoters.
    Gustavson MD; Crawford HC; Fingleton B; Matrisian LM
    Mol Carcinog; 2004 Nov; 41(3):125-39. PubMed ID: 15457508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of MYCBP as a beta-catenin/LEF-1 target using DNA microarray analysis.
    Jung HC; Kim K
    Life Sci; 2005 Jul; 77(11):1249-62. PubMed ID: 15979100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antagonistic regulation of Dlx2 expression by PITX2 and Msx2: implications for tooth development.
    Green PD; Hjalt TA; Kirk DE; Sutherland LB; Thomas BL; Sharpe PT; Snead ML; Murray JC; Russo AF; Amendt BA
    Gene Expr; 2001; 9(6):265-81. PubMed ID: 11763998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beta-catenin can act as a nuclear import receptor for its partner transcription factor, lymphocyte enhancer factor-1 (lef-1).
    Asally M; Yoneda Y
    Exp Cell Res; 2005 Aug; 308(2):357-63. PubMed ID: 15936755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A second protein kinase CK1-mediated step negatively regulates Wnt signalling by disrupting the lymphocyte enhancer factor-1/beta-catenin complex.
    Hämmerlein A; Weiske J; Huber O
    Cell Mol Life Sci; 2005 Mar; 62(5):606-18. PubMed ID: 15747065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chromatin-specific regulation of LEF-1-beta-catenin transcription activation and inhibition in vitro.
    Tutter AV; Fryer CJ; Jones KA
    Genes Dev; 2001 Dec; 15(24):3342-54. PubMed ID: 11751639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T-cell factor 4N (TCF-4N), a novel isoform of mouse TCF-4, synergizes with beta-catenin to coactivate C/EBPalpha and steroidogenic factor 1 transcription factors.
    Kennell JA; O'Leary EE; Gummow BM; Hammer GD; MacDougald OA
    Mol Cell Biol; 2003 Aug; 23(15):5366-75. PubMed ID: 12861022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of the versican promoter by the beta-catenin-T-cell factor complex in vascular smooth muscle cells.
    Rahmani M; Read JT; Carthy JM; McDonald PC; Wong BW; Esfandiarei M; Si X; Luo Z; Luo H; Rennie PS; McManus BM
    J Biol Chem; 2005 Apr; 280(13):13019-28. PubMed ID: 15668231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein inhibitors of activated STAT (Pias1 and Piasy) differentially regulate pituitary homeobox 2 (PITX2) transcriptional activity.
    Wang J; Sun Z; Zhang Z; Saadi I; Wang J; Li X; Gao S; Engle JJ; Kuburas A; Fu X; Yu W; Klein WH; Russo AF; Amendt BA
    J Biol Chem; 2013 May; 288(18):12580-95. PubMed ID: 23515314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microphthalmia-associated transcription factor interacts with LEF-1, a mediator of Wnt signaling.
    Yasumoto K; Takeda K; Saito H; Watanabe K; Takahashi K; Shibahara S
    EMBO J; 2002 Jun; 21(11):2703-14. PubMed ID: 12032083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymphoid enhancer factor 1 makes cells resistant to transforming growth factor beta-induced repression of c-myc.
    Sasaki T; Suzuki H; Yagi K; Furuhashi M; Yao R; Susa S; Noda T; Arai Y; Miyazono K; Kato M
    Cancer Res; 2003 Feb; 63(4):801-6. PubMed ID: 12591729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The C-terminal transactivation domain of beta-catenin is necessary and sufficient for signaling by the LEF-1/beta-catenin complex in Xenopus laevis.
    Vleminckx K; Kemler R; Hecht A
    Mech Dev; 1999 Mar; 81(1-2):65-74. PubMed ID: 10330485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of a BCL9-related beta-catenin-binding protein, B9L, in tumorigenesis induced by aberrant activation of Wnt signaling.
    Adachi S; Jigami T; Yasui T; Nakano T; Ohwada S; Omori Y; Sugano S; Ohkawara B; Shibuya H; Nakamura T; Akiyama T
    Cancer Res; 2004 Dec; 64(23):8496-501. PubMed ID: 15574752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beta-catenin directly displaces Groucho/TLE repressors from Tcf/Lef in Wnt-mediated transcription activation.
    Daniels DL; Weis WI
    Nat Struct Mol Biol; 2005 Apr; 12(4):364-71. PubMed ID: 15768032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dynamic expression of Lef/Tcf family members and beta-catenin during chick gastrulation, neurulation, and early limb development.
    Schmidt M; Patterson M; Farrell E; Münsterberg A
    Dev Dyn; 2004 Mar; 229(3):703-7. PubMed ID: 14991726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Morphological and transcriptional responses of untransformed intestinal epithelial cells to an oncogenic beta-catenin protein.
    Naishiro Y; Yamada T; Idogawa M; Honda K; Takada M; Kondo T; Imai K; Hirohashi S
    Oncogene; 2005 Apr; 24(19):3141-53. PubMed ID: 15735679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional interactions between Dlx2 and lymphoid enhancer factor regulate Msx2.
    Diamond E; Amen M; Hu Q; Espinoza HM; Amendt BA
    Nucleic Acids Res; 2006; 34(20):5951-65. PubMed ID: 17068080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.